To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

18F-AV-1451 in Parkinson'… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies.

Journal article
Authors Ruben Smith
Michael Schöll
Elisabet Londos
Tomas Ohlsson
Oskar Hansson
Published in Scientific Reports
Volume 8
Issue 1
Pages 1-6
ISSN 2045-2322
Publication year 2018
Published at Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Pages 1-6
Language en
Subject categories Radiology, Nuclear Medicine and Medical Imaging, Neurology


Mixed pathologies of α-synuclein, β-amyloid and tau are relatively common in Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB). We therefore wanted to study the retention patterns of18F-AV-1451 in PD, PD-dementia (PDD), and DLB. To do this 44 healthy controls, 11 non-demented patients with PD, 18 patients with PDD, and six patients with DLB underwent MRI and18F-AV-1451 PET scanning and cognitive testing. We found that parietal18F-AV-1451 retention was increased in patients with DLB compared to controls and PD patients, while18F-AV-1451 uptake was reduced in the substantia nigra in PDD. Increased parietal18F-AV-1451 PET uptake was associated with impaired performance on verbal fluency tests, and the decreased uptake in the substantia nigra correlated with worse motor function. We found no effect of the monoamine oxidase B inhibitor rasagiline on18F-AV-1451 binding. In conclusion DLB patients have increased parietal18F-AV-1451 uptake. Increased parietal tau is associated with executive impairment in patients with synucleinopathies, while decreased uptake in the substantia nigra is associated with parkinsonism. Further, our data indicate that18F-AV-1451 does not significantly bind to MAO-B in vivo.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?